Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...

Behavior Therapy

Behavior Therapy

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

Autism Spectrum Disorder

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

Modeling in Therapy

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An algorithm to predict intrathecal IgM synthesis in multiple sclerosis patients: optimizing the use of oligoclonal band testing.

Advances in laboratory medicine·2026

Same author

Analysis of Corrosion by Speckle Polarimetry.

Sensors (Basel, Switzerland)·2025

Same author

Use of immune checkpoint inhibitors in patients with lung cancer and multiple sclerosis.

Lung cancer (Amsterdam, Netherlands)·2025

Same author

Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2024

Same author

Renal function's impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2024

Same author

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis.

Frontiers in neurology·2022

Search research articles

Related Experiment Video

Updated: Oct 6, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Escalation vs. Early Intense Therapy in Multiple Sclerosis.

Bonaventura Casanova¹, Carlos Quintanilla-Bordás¹, Francisco Gascón²

¹Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe. València, la Universitat de València, 46026 Valencia, Spain.

Journal of Personalized Medicine

|January 21, 2022

Summary

The optimal multiple sclerosis (MS) treatment strategy remains debated. This review critically examines the "escalation strategy" versus "early intense therapy" for MS management, summarizing current evidence for both approaches.

Keywords:

diseases modifying therapies early intense therapy escalating strategy he-DMT multiple sclerosis treatment

More Related Videos

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

Related Experiment Videos

Last Updated: Oct 6, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

Area of Science:

Neurology
Immunology
Pharmacology

Background:

Multiple sclerosis (MS) treatment lacks definitive guidance on initial drug choice, treatment failure, or subsequent therapies.
Up to 19 drugs are approved for MS, yet optimal therapeutic strategies are debated.
Current MS treatment strategies include "escalation therapy" and "early intense therapy".

Purpose of the Study:

To critically review the evidence supporting the "escalation strategy" and "early intense therapy" for multiple sclerosis.
To compare the long-term benefits and risks of different MS treatment approaches.
To inform the ongoing debate on optimal multiple sclerosis management.

Main Methods:

Critical review of existing scientific literature and clinical studies.
Analysis of evidence supporting the "escalation strategy" (low efficacy/low side-effect drugs first).
Analysis of evidence supporting "early intense therapy" (high efficacy drugs from the start).

Main Results:

The "escalation strategy" is based on short-term data and may not account for disease heterogeneity or long-term outcomes.
"Early intense therapy" aims to maximize long-term benefits by leveraging the "window of opportunity".
Evidence supporting either strategy's long-term superiority is limited, and the debate continues.

Conclusions:

The optimal treatment strategy for multiple sclerosis is not definitively established.
Both "escalation therapy" and "early intense therapy" have potential benefits and drawbacks.
Further research is needed to guide fundamental decisions in multiple sclerosis management.